Fewer Warning Letters: Does Change Point To FDA Advancement Or Decline?
This article was originally published in The Pink Sheet Daily
Executive Summary
“Voluntary compliance” by drug firms is resulting in fewer CDER warning letters, FDAer states; House Government Reform Committee investigates a “decline” in enforcement activity by the agency since 2000.